Treatment of nontuberculous mycobacterial infections: Role of clarithromycin and azithromycin

被引:32
作者
Tartaglione, T [1 ]
机构
[1] INFECT DIS PHARMACOTHERAPY,EDMONDS,WA
关键词
mycobacteria; Mycobacterium avium complex; Mycobacterium kansasii; Mycobacterium fortuitum/chelonei complex; Mycobacterium genavense; clarithromycin; azithromycin;
D O I
10.1016/S0149-2918(97)80088-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The incidence of identification of nontuberculous mycobacteria has increased since the advent of the acquired immunodeficiency syndrome epidemic. Although Mycobacterium avium complex appears to be responsible for most episodes of nontuberculous disease, several other previously rare species are increasingly being detected, including Mycobacterium kansasii, Mycobacterium fortuitum/chelonei complex, and Mycobacterium genavense. This review briefly summarizes the epidemiology and clinical features of these infections, as well as therapeutic and preventive strategies in immunosuppressed patients with nontuberculous mycobacterial infections. Of clinical relevance, nontuberculous mycobacterial infections are difficult to treat and do not respond to traditional antituberculous agents. The search for more effective treatment regimens is ongoing in an attempt to enhance survival and reduce morbidity among immunocompromised patients. Novel antimicrobial combinations that include clarithromycin or azithromycin have been shown to be effective in treating several nontuberculous mycobacterial infections.
引用
收藏
页码:626 / 638
页数:13
相关论文
共 56 条
  • [1] MYCOBACTERIUM-KANSASII AMONG PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS IN KANSAS-CITY
    BAMBERGER, DR
    DRIKS, MR
    GUPTA, MR
    OCONNOR, MC
    JOST, PM
    NEIHART, RE
    MCKINSEY, DS
    MOORE, LA
    BREWER, J
    SMITH, D
    DALL, L
    STANFORD, J
    HODGES, G
    WALLACE, J
    LEE, S
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 18 (03) : 395 - 400
  • [2] MYCOBACTERIUM-AVIUM COMPLEX INFECTION AND AIDS - ADVANCES IN THEORY AND PRACTICE
    BENSON, CA
    ELLNER, JJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 17 (01) : 7 - 20
  • [3] BENSON CA, 1996, 3 NAT C RETR OPP INF
  • [4] MYCOBACTERIUM GENAVENSE INFECTION PRESENTING AS A SOLITARY BRAIN MASS IN A PATIENT WITH AIDS - CASE-REPORT AND REVIEW
    BERMAN, SM
    KIM, RC
    HAGHIGHAT, D
    MULLIGAN, ME
    FIERER, J
    WYLE, FC
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 19 (06) : 1152 - 1154
  • [5] DISSEMINATED MYCOBACTERIUM-GENAVENSE INFECTION - CLINICAL AND MICROBIOLOGICAL FEATURES AND RESPONSE TO THERAPY
    BESSESEN, MT
    SHLAY, J
    STONEVENOHR, B
    COHN, DL
    REVES, RR
    [J]. AIDS, 1993, 7 (10) : 1357 - 1361
  • [6] INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-KANSASII TO CLARITHROMYCIN
    BIEHLE, J
    CAVALIERI, SJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) : 2039 - 2041
  • [7] Rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis
    Bishai, WR
    Graham, NMH
    Harrington, S
    Page, C
    MooreRice, K
    Hooper, N
    Chaisson, RE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (24) : 1573 - 1576
  • [8] DISSEMINATED MYCOBACTERIUM-GENAVENSE INFECTION IN PATIENTS WITH AIDS
    BOTTGER, EC
    TESKE, A
    KIRSCHNER, P
    BOST, S
    CHANG, HR
    BEER, V
    HIRSCHEL, B
    [J]. LANCET, 1992, 340 (8811) : 76 - 80
  • [9] ACTIVITIES OF 4 MACROLIDES, INCLUDING CLARITHROMYCIN, AGAINST MYCOBACTERIUM-FORTUITUM, MYCOBACTERIUM-CHELONAE, AND M-CHELONAE-LIKE ORGANISMS
    BROWN, BA
    WALLACE, RJ
    ONYI, GO
    DEROSAS, V
    WALLACE, RJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) : 180 - 184
  • [10] *CDC, 1987, ANN INTERN MED, V106, P254